1 code implementation • 23 May 2023 • Abhineet Singh, Ila Jasra, Omar Mouhammed, Nidheesh Dadheech, Nilanjan Ray, James Shapiro
This paper presents advancements in automated early-stage prediction of the success of reprogramming human induced pluripotent stem cells (iPSCs) as a potential source for regenerative cell therapies. The minuscule success rate of iPSC-reprogramming of around $ 0. 01% $ to $ 0. 1% $ makes it labor-intensive, time-consuming, and exorbitantly expensive to generate a stable iPSC line.